US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

8.62

+0.22002.62%

Volume:225.36K

Turnover:1.92M

Market Cap:591.63M

PE:-4.77

High:8.76

Open:8.34

Low:8.19

Close:8.40

52wk High:11.54

52wk Low:2.86

Shares:68.63M

Float Shares:39.65M

Volume Ratio:0.53

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8064

EPS(LYR):-2.2041

ROE:-59.22%

ROA:-34.41%

PB:1.92

PE(LYR):-3.91

Loading ...

Overview Company News Filings

Oppenheimer Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)

Promising Developments and Strategic Collaborations Boost Olema Pharmaceuticals’ Buy Rating

Optimistic Buy Rating for Olema Pharmaceuticals Driven by Unique Phase III Trials and Promising Market Potential

Olema Pharmaceuticals Q3 EPS $(0.49) Misses $(0.45) Estimate

Olema Pharmaceuticals posts Q3 net loss of $42.2 million on higher R&D spending

BRIEF-Olema Pharmaceuticals Q3 Net Income USD -42.217 Million

Olema Pharmaceuticals Q3 Income From Operations USD -45.877 Million

THOMSON REUTERS

Press Release: Olema Oncology Reports Third Quarter 2025 Financial and Operating Results

Olema Pharmaceuticals Inc expected to post a loss of 48 cents a share - Earnings Preview

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Olema Pharmaceuticals Inc. to Participate in Jefferies London Healthcare Conference

Olema Pharmaceuticals Announces Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib for Advanced Breast Cancer

Promising Outlook for Olema Pharmaceuticals: Buy Rating Driven by Palazestrant’s Potential in Breast Cancer Treatment

JPMorgan healthcare analysts hold an analyst/industry conference call

Olema Pharmaceuticals Reports Positive Phase 1b/2 Trial Results

Olema Pharmaceuticals Shares Fall After Roche's Breast Cancer Data Weighs on Sector

MT Newswires Live

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Olema Pharmaceuticals Price Target Maintained With a $28.00/Share by HC Wainwright & Co.

Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’

Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OLMA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OLMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OLMA\",,,,,undefined,":{"symbol":"OLMA","market":"US","secType":"STK","nameCN":"Olema Pharmaceuticals, Inc.","latestPrice":8.62,"timestamp":1763399815047,"preClose":8.4,"halted":0,"volume":225356,"delay":0,"floatShares":39645288,"shares":68634329,"eps":-1.806432,"marketStatus":"Trading","change":0.22,"latestTime":"11-17 12:17:02 EST","open":8.34,"high":8.762,"low":8.19,"amount":1916396.324872,"amplitude":0.068095,"askPrice":8.63,"askSize":100,"bidPrice":8.61,"bidSize":254,"shortable":3,"etf":0,"ttmEps":-1.806432,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1763413200000},"marketStatusCode":2,"adr":0,"listingDate":1605762000000,"exchange":"NASDAQ","adjPreClose":8.4,"preHourTrading":{"tag":"盘前","latestPrice":8.52,"preClose":8.4,"latestTime":"09:14 EST","volume":729,"amount":6143.620527,"timestamp":1763388848813},"postHourTrading":{"tag":"盘后","latestPrice":8.4,"preClose":8.4,"latestTime":"16:45 EST","volume":17789,"amount":149433.6401,"timestamp":1763156754609},"volumeRatio":0.528161,"impliedVol":1.1246,"impliedVolPercentile":0.492},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OLMA\",,,,,undefined,":{"symbol":"OLMA","floatShares":39645288,"roa":"-34.41%","roe":"-59.22%","lyrEps":-2.204055,"volumeRatio":0.528161,"shares":68634329,"dividePrice":0,"high":8.762,"amplitude":0.068095,"preClose":8.4,"low":8.19,"week52Low":2.86,"pbRate":"1.92","week52High":11.5439,"institutionHeld":0,"latestPrice":8.62,"committee":0.435028,"eps":-1.806432,"divideRate":0,"volume":225356,"delay":0,"ttmEps":-1.806432,"open":8.34,"prevYearClose":5.83,"prevWeekClose":8.4,"prevMonthClose":8.97,"prevQuarterClose":9.79,"fiveDayClose":8.7,"twentyDayClose":7.77,"sixtyDayClose":5.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OLMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"OLMA","fiscalQuarterEnding":"2025/09","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.49},{"market":"US","date":"2025-08-11","symbol":"OLMA","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2025-05-13","symbol":"OLMA","fiscalQuarterEnding":"2025/03","expectedEps":-0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2025-03-18","symbol":"OLMA","fiscalQuarterEnding":"2024/12","expectedEps":-0.63,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2024-11-12","symbol":"OLMA","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OLMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OLMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1759986000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OLMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OLMA","date":"2025-11-14","current":-4.722016,"percent":0.552653,"low":-160.371485,"twenty":-20.337251,"median":-4.188672,"eighty":-2.042786,"high":-0.908267,"avg":-16.290371,"sd":32.90944,"marketCap":545159788},"quantilePoints":[{"date":"2020-11-20","current":-137.689749,"twenty":-137.802379,"median":-95.594417,"eighty":-53.499085,"marketCap":1790930568},{"date":"2020-11-27","current":-146.541284,"twenty":-146.188172,"median":-138.298512,"eighty":-87.175351,"marketCap":1906062480},{"date":"2020-12-04","current":-144.187207,"twenty":-153.215092,"median":-145.658505,"eighty":-137.802379,"marketCap":1875443003},{"date":"2020-12-11","current":-127.355558,"twenty":-149.872303,"median":-138.298512,"eighty":-127.873455,"marketCap":1656513738},{"date":"2020-12-18","current":-129.474227,"twenty":-148.359808,"median":-134.564918,"eighty":-118.062839,"marketCap":1684071268},{"date":"2020-12-24","current":-151.543697,"twenty":-148.965983,"median":-136.065642,"eighty":-119.863708,"marketCap":1971128870},{"date":"2020-12-31","current":-141.480019,"twenty":-146.541284,"median":-137.689749,"eighty":-126.149093,"marketCap":1840230603},{"date":"2021-01-08","current":-124.20698,"twenty":-146.394154,"median":-135.31528,"eighty":-124.530665,"marketCap":1615560186},{"date":"2021-01-15","current":-122.971089,"twenty":-145.658505,"median":-132.210841,"eighty":-122.971089,"marketCap":1599484961},{"date":"2021-01-22","current":-132.269693,"twenty":-144.481467,"median":-129.474227,"eighty":-123.135875,"marketCap":1720431897},{"date":"2021-01-29","current":-124.913203,"twenty":-143.622229,"median":-130.842534,"eighty":-123.506642,"marketCap":1624746030},{"date":"2021-02-05","current":-139.479053,"twenty":-143.433902,"median":-128.6503,"eighty":-123.506642,"marketCap":1814204047},{"date":"2021-02-12","current":-140.067573,"twenty":-145.776209,"median":-132.240267,"eighty":-123.589035,"marketCap":1821858917},{"date":"2021-02-19","current":-157.840853,"twenty":-146.453006,"median":-134.491353,"eighty":-123.747935,"marketCap":2053035973},{"date":"2021-02-26","current":-117.468435,"twenty":-146.453006,"median":-132.269693,"eighty":-123.589035,"marketCap":1527911932},{"date":"2021-03-05","current":-110.818168,"twenty":-146.305876,"median":-129.209393,"eighty":-122.729797,"marketCap":1441411908},{"date":"2021-03-12","current":-138.655126,"twenty":-145.893913,"median":-128.944559,"eighty":-122.217785,"marketCap":1803487230},{"date":"2021-03-19","current":-78.972283,"twenty":-145.823291,"median":-128.797429,"eighty":-121.499791,"marketCap":1746945869},{"date":"2021-03-26","current":-54.335783,"twenty":-144.775726,"median":-127.061298,"eighty":-117.733268,"marketCap":1201961853},{"date":"2021-04-01","current":-61.306023,"twenty":-143.904718,"median":-126.531631,"eighty":-113.902008,"marketCap":1356150529},{"date":"2021-04-09","current":-58.542884,"twenty":-143.457443,"median":-126.340362,"eighty":-107.940309,"marketCap":1295027140},{"date":"2021-04-16","current":-64.425695,"twenty":-143.410362,"median":-125.854834,"eighty":-72.383534,"marketCap":1425160806},{"date":"2021-04-23","current":-55.334078,"twenty":-143.180839,"median":-125.178036,"eighty":-63.402443,"marketCap":1224045141},{"date":"2021-04-30","current":-50.003895,"twenty":-142.309831,"median":-124.20698,"eighty":-61.505682,"marketCap":1106136154},{"date":"2021-05-07","current":-38.505673,"twenty":-140.915041,"median":-123.721452,"eighty":-58.785327,"marketCap":851783990},{"date":"2021-05-14","current":-27.703592,"twenty":-139.832165,"median":-123.177071,"eighty":-57.03118,"marketCap":990874372},{"date":"2021-05-21","current":-27.637395,"twenty":-139.149482,"median":-122.691543,"eighty":-56.08993,"marketCap":988506692},{"date":"2021-05-28","current":-30.847966,"twenty":-138.643356,"median":-121.735199,"eighty":-53.833764,"marketCap":1103339206},{"date":"2021-06-04","current":-30.572144,"twenty":-138.494825,"median":-118.969159,"eighty":-53.376706,"marketCap":1093473869},{"date":"2021-06-11","current":-31.785762,"twenty":-137.915008,"median":-117.68913,"eighty":-46.70952,"marketCap":1136881349},{"date":"2021-06-18","current":-27.041618,"twenty":-137.670958,"median":-115.526321,"eighty":-38.601937,"marketCap":967197565},{"date":"2021-06-25","current":-33.164873,"twenty":-137.360384,"median":-110.950584,"eighty":-33.032479,"marketCap":1186208030},{"date":"2021-07-02","current":-29.424723,"twenty":-136.348131,"median":-107.139923,"eighty":-31.829894,"marketCap":1052434071},{"date":"2021-07-09","current":-29.358526,"twenty":-136.065642,"median":-79.489257,"eighty":-30.991394,"marketCap":1050066390},{"date":"2021-07-16","current":-26.986454,"twenty":-135.535975,"median":-67.576564,"eighty":-30.870032,"marketCap":965224498},{"date":"2021-07-23","current":-28.486927,"twenty":-134.564918,"median":-63.926548,"eighty":-30.494914,"marketCap":1018891927},{"date":"2021-07-30","current":-25.905231,"twenty":-134.417788,"median":-62.402365,"eighty":-29.799841,"marketCap":926552380},{"date":"2021-08-06","current":-28.83998,"twenty":-134.270658,"median":-61.306023,"eighty":-28.961342,"marketCap":1031519558},{"date":"2021-08-13","current":-21.003404,"twenty":-132.269693,"median":-59.478786,"eighty":-28.531059,"marketCap":1044289255},{"date":"2021-08-20","current":-21.583349,"twenty":-132.210841,"median":-58.328964,"eighty":-28.288335,"marketCap":1073124108},{"date":"2021-08-27","current":-23.613156,"twenty":-131.828304,"median":-57.036528,"eighty":-28.012513,"marketCap":1174046092},{"date":"2021-09-03","current":-23.056722,"twenty":-129.474227,"median":-56.56412,"eighty":-27.482934,"marketCap":1146380220},{"date":"2021-09-10","current":-22.962677,"twenty":-129.050493,"median":-56.047146,"eighty":-27.174013,"marketCap":1141704298},{"date":"2021-09-17","current":-21.457955,"twenty":-128.709152,"median":-54.80819,"eighty":-26.953355,"marketCap":1066889545},{"date":"2021-09-24","current":-22.312198,"twenty":-127.614506,"median":-53.499085,"eighty":-26.58265,"marketCap":1109362503},{"date":"2021-10-01","current":-22.805935,"twenty":-127.12015,"median":-52.463979,"eighty":-26.399504,"marketCap":1133911094},{"date":"2021-10-08","current":-21.465793,"twenty":-126.920053,"median":-49.576054,"eighty":-25.746357,"marketCap":1067279205},{"date":"2021-10-15","current":-24.067707,"twenty":-126.602253,"median":-40.41313,"eighty":-23.849253,"marketCap":1196646382},{"date":"2021-10-22","current":-21.771439,"twenty":-126.531631,"median":-38.505673,"eighty":-23.505003,"marketCap":1082475952},{"date":"2021-10-29","current":-21.160146,"twenty":-126.461009,"median":-33.413114,"eighty":-23.401554,"marketCap":1052082459},{"date":"2021-11-05","current":-21.857647,"twenty":-126.278567,"median":-32.767689,"eighty":-23.124121,"marketCap":1086762214},{"date":"2021-11-12","current":-18.022011,"twenty":-126.166749,"median":-31.896091,"eighty":-23.014402,"marketCap":1073913601},{"date":"2021-11-19","current":-15.180643,"twenty":-125.913686,"median":-31.201019,"eighty":-22.790261,"marketCap":904599318},{"date":"2021-11-26","current":-13.920036,"twenty":-125.801867,"median":-30.969328,"eighty":-22.528502,"marketCap":829481009},{"date":"2021-12-03","current":-6.983362,"twenty":-125.572344,"median":-30.870032,"eighty":-22.33571,"marketCap":416131584},{"date":"2021-12-10","current":-6.816615,"twenty":-125.12507,"median":-30.572144,"eighty":-21.943855,"marketCap":406195300},{"date":"2021-12-17","current":-6.416423,"twenty":-124.68368,"median":-30.489398,"eighty":-21.809057,"marketCap":382348217},{"date":"2021-12-23","current":-6.609849,"twenty":-124.401191,"median":-30.219092,"eighty":-21.633506,"marketCap":393874307},{"date":"2021-12-31","current":-6.243006,"twenty":-124.077506,"median":-29.424723,"eighty":-21.46109,"marketCap":372014482},{"date":"2022-01-07","current":-4.869011,"twenty":-123.871524,"median":-29.193033,"eighty":-21.371747,"marketCap":290139500},{"date":"2022-01-14","current":-4.462148,"twenty":-123.747935,"median":-28.83998,"eighty":-21.160146,"marketCap":265894966},{"date":"2022-01-21","current":-3.968578,"twenty":-123.589035,"median":-28.531059,"eighty":-21.042589,"marketCap":236483565},{"date":"2022-01-28","current":-3.921888,"twenty":-123.506642,"median":-28.415214,"eighty":-21.003404,"marketCap":233701405},{"date":"2022-02-04","current":-3.921888,"twenty":-123.135875,"median":-28.166973,"eighty":-20.35606,"marketCap":233701405},{"date":"2022-02-11","current":-3.328269,"twenty":-122.953434,"median":-28.045611,"eighty":-17.893949,"marketCap":198328233},{"date":"2022-02-18","current":-3.001445,"twenty":-122.806304,"median":-27.703592,"eighty":-16.672027,"marketCap":178853116},{"date":"2022-02-25","current":-3.068144,"twenty":-122.500274,"median":-27.482934,"eighty":-14.598696,"marketCap":182827630},{"date":"2022-03-04","current":-2.52257,"twenty":-121.794051,"median":-27.339506,"eighty":-7.750398,"marketCap":179344633},{"date":"2022-03-11","current":-2.472119,"twenty":-121.735199,"median":-27.019553,"eighty":-6.983362,"marketCap":175757740},{"date":"2022-03-18","current":-2.786038,"twenty":-121.14668,"median":-26.903707,"eighty":-6.523141,"marketCap":198076184},{"date":"2022-03-25","current":-2.505753,"twenty":-118.969159,"median":-26.6665,"eighty":-6.369734,"marketCap":178149002},{"date":"2022-04-01","current":-2.298342,"twenty":-118.292362,"median":-26.545138,"eighty":-6.269685,"marketCap":163402888},{"date":"2022-04-08","current":-2.018056,"twenty":-117.909824,"median":-26.401711,"eighty":-6.129618,"marketCap":143475706},{"date":"2022-04-14","current":-1.726559,"twenty":-117.556713,"median":-25.949362,"eighty":-5.90551,"marketCap":122751438},{"date":"2022-04-22","current":-1.597628,"twenty":-116.197233,"median":-25.590793,"eighty":-4.885019,"marketCap":113584934},{"date":"2022-04-29","current":-1.429645,"twenty":-115.596943,"median":-23.942313,"eighty":-4.552858,"marketCap":101642020},{"date":"2022-05-06","current":-1.250238,"twenty":-113.360571,"median":-23.593563,"eighty":-4.286064,"marketCap":88886943},{"date":"2022-05-13","current":-1.094131,"twenty":-111.430227,"median":-23.511273,"eighty":-4.128654,"marketCap":86203297},{"date":"2022-05-20","current":-1.144785,"twenty":-110.871135,"median":-23.428984,"eighty":-3.921888,"marketCap":90194190},{"date":"2022-05-27","current":-1.494299,"twenty":-109.476344,"median":-23.401554,"eighty":-3.792492,"marketCap":117731355},{"date":"2022-06-03","current":-1.701982,"twenty":-107.940309,"median":-23.182115,"eighty":-3.446993,"marketCap":134094018},{"date":"2022-06-10","current":-2.180664,"twenty":-95.983102,"median":-23.111582,"eighty":-3.194872,"marketCap":171807960},{"date":"2022-06-17","current":-1.828617,"twenty":-83.111643,"median":-23.025374,"eighty":-3.010102,"marketCap":144071251},{"date":"2022-06-24","current":-2.213589,"twenty":-79.282467,"median":-22.962677,"eighty":-2.868598,"marketCap":174402041},{"date":"2022-07-01","current":-2.117346,"twenty":-74.579784,"median":-22.76675,"eighty":-2.736708,"marketCap":166819344},{"date":"2022-07-08","current":-2.446598,"twenty":-67.825247,"median":-22.570822,"eighty":-2.671682,"marketCap":192760151},{"date":"2022-07-15","current":-2.380748,"twenty":-66.614814,"median":-22.414081,"eighty":-2.546114,"marketCap":187571989},{"date":"2022-07-22","current":-2.461795,"twenty":-64.325866,"median":-22.33571,"eighty":-2.506079,"marketCap":193957419},{"date":"2022-07-29","current":-2.542841,"twenty":-63.751846,"median":-21.990878,"eighty":-2.478846,"marketCap":200342848},{"date":"2022-08-05","current":-2.978468,"twenty":-62.995994,"median":-21.904669,"eighty":-2.506079,"marketCap":234664531},{"date":"2022-08-12","current":-1.70625,"twenty":-62.621633,"median":-21.834136,"eighty":-2.462808,"marketCap":162501544},{"date":"2022-08-19","current":-1.68944,"twenty":-61.990568,"median":-21.720498,"eighty":-2.448339,"marketCap":160900544},{"date":"2022-08-26","current":-1.744073,"twenty":-61.705341,"median":-21.583349,"eighty":-2.391641,"marketCap":166103795},{"date":"2022-09-02","current":-1.458297,"twenty":-61.220455,"median":-21.461874,"eighty":-2.381761,"marketCap":138886788},{"date":"2022-09-09","current":-1.773491,"twenty":-60.878182,"median":-21.422688,"eighty":-2.330094,"marketCap":168905546},{"date":"2022-09-16","current":-1.584375,"twenty":-59.80858,"median":-21.371747,"eighty":-2.298342,"marketCap":150894291},{"date":"2022-09-23","current":-1.20194,"twenty":-59.148992,"median":-21.195413,"eighty":-2.231073,"marketCap":114471531},{"date":"2022-09-30","current":-1.159914,"twenty":-58.542884,"median":-21.160146,"eighty":-2.203044,"marketCap":110469030},{"date":"2022-10-07","current":-1.164116,"twenty":-58.328964,"median":-21.022996,"eighty":-2.180622,"marketCap":110869280},{"date":"2022-10-14","current":-1.20194,"twenty":-57.901123,"median":-21.003404,"eighty":-2.061626,"marketCap":114471531},{"date":"2022-10-21","current":-1.470905,"twenty":-57.063268,"median":-20.658572,"eighty":-1.899533,"marketCap":140087538},{"date":"2022-10-28","current":-1.559159,"twenty":-57.009788,"median":-20.337251,"eighty":-1.85901,"marketCap":148492790},{"date":"2022-11-04","current":-1.416272,"twenty":-56.902828,"median":-18.045355,"eighty":-1.81972,"marketCap":134884287},{"date":"2022-11-11","current":-1.352398,"twenty":-56.56412,"median":-17.641828,"eighty":-1.794504,"marketCap":135572465},{"date":"2022-11-18","current":-1.052309,"twenty":-56.154106,"median":-16.748064,"eighty":-1.771405,"marketCap":105489818},{"date":"2022-11-25","current":-1.260371,"twenty":-56.068538,"median":-14.983881,"eighty":-1.754975,"marketCap":126347120},{"date":"2022-12-02","current":-1.092321,"twenty":-55.476692,"median":-14.173491,"eighty":-1.726559,"marketCap":109500837},{"date":"2022-12-09","current":-0.976287,"twenty":-55.291294,"median":-10.688479,"eighty":-1.713133,"marketCap":97868880},{"date":"2022-12-16","current":-0.932274,"twenty":-54.524746,"median":-7.383555,"eighty":-1.683556,"marketCap":93456759},{"date":"2022-12-23","current":-1.060312,"twenty":-53.666425,"median":-6.930003,"eighty":-1.643063,"marketCap":106292022},{"date":"2022-12-30","current":-0.980288,"twenty":-53.499085,"median":-6.713232,"eighty":-1.594008,"marketCap":98269982},{"date":"2023-01-06","current":-1.140335,"twenty":-53.455838,"median":-6.473117,"eighty":-1.581853,"marketCap":114314061},{"date":"2023-01-13","current":-1.660488,"twenty":-53.383837,"median":-6.409753,"eighty":-1.571465,"marketCap":166457317},{"date":"2023-01-20","current":-1.860547,"twenty":-53.009476,"median":-6.363064,"eighty":-1.57681,"marketCap":186512416},{"date":"2023-01-27","current":-1.884554,"twenty":-51.244633,"median":-6.27969,"eighty":-1.581013,"marketCap":188919027},{"date":"2023-02-03","current":-1.820535,"twenty":-49.918327,"median":-6.243006,"eighty":-1.585216,"marketCap":182501396},{"date":"2023-02-10","current":-1.816534,"twenty":-48.859421,"median":-6.112944,"eighty":-1.588578,"marketCap":182100294},{"date":"2023-02-17","current":-1.820535,"twenty":-45.115813,"median":-5.922852,"eighty":-1.590388,"marketCap":182501396},{"date":"2023-02-24","current":-1.640482,"twenty":-41.607519,"median":-5.409271,"eighty":-1.597628,"marketCap":164451807},{"date":"2023-03-03","current":-1.640482,"twenty":-39.218741,"median":-4.879016,"eighty":-1.597628,"marketCap":164451807},{"date":"2023-03-10","current":-1.508369,"twenty":-38.986994,"median":-4.682254,"eighty":-1.580465,"marketCap":158057499},{"date":"2023-03-17","current":-1.407553,"twenty":-38.505673,"median":-4.418794,"eighty":-1.567565,"marketCap":147493245},{"date":"2023-03-24","current":-1.39592,"twenty":-37.703471,"median":-4.288732,"eighty":-1.556458,"marketCap":146274292},{"date":"2023-03-31","current":-1.345512,"twenty":-33.661354,"median":-4.222033,"eighty":-1.543267,"marketCap":140992165},{"date":"2023-04-06","current":-1.248573,"twenty":-33.264169,"median":-4.11865,"eighty":-1.524739,"marketCap":130834228},{"date":"2023-04-14","current":-1.469594,"twenty":-33.032479,"median":-3.948568,"eighty":-1.512794,"marketCap":153994324},{"date":"2023-04-21","current":-1.597553,"twenty":-32.814027,"median":-3.921888,"eighty":-1.508429,"marketCap":167402801},{"date":"2023-04-28","current":-1.795309,"twenty":-32.352852,"median":-3.8085,"eighty":-1.511486,"marketCap":188124993},{"date":"2023-05-05","current":-2.466505,"twenty":-32.054965,"median":-3.488347,"eighty":-1.512794,"marketCap":258457661},{"date":"2023-05-12","current":-2.51514,"twenty":-31.829894,"median":-3.328269,"eighty":-1.518065,"marketCap":276773559},{"date":"2023-05-19","current":-2.478153,"twenty":-31.785762,"median":-3.194872,"eighty":-1.520938,"marketCap":272703359},{"date":"2023-05-26","current":-1.983895,"twenty":-31.317968,"median":-3.043901,"eighty":-1.523371,"marketCap":218313708},{"date":"2023-06-02","current":-2.1164,"twenty":-31.075244,"median":-3.001445,"eighty":-1.524524,"marketCap":232894958},{"date":"2023-06-09","current":-2.410855,"twenty":-30.978154,"median":-2.940357,"eighty":-1.530348,"marketCap":265297735},{"date":"2023-06-16","current":-3.342071,"twenty":-30.942849,"median":-2.978468,"eighty":-1.535157,"marketCap":367771516},{"date":"2023-06-23","current":-3.062338,"twenty":-30.90313,"median":-3.001445,"eighty":-1.538886,"marketCap":336988878},{"date":"2023-06-30","current":-3.244533,"twenty":-30.870032,"median":-3.001445,"eighty":-1.544764,"marketCap":357038096},{"date":"2023-07-07","current":-3.323668,"twenty":-30.870032,"median":-3.043901,"eighty":-1.550754,"marketCap":365746343},{"date":"2023-07-14","current":-3.209566,"twenty":-30.847966,"median":-3.079964,"eighty":-1.550754,"marketCap":353190267},{"date":"2023-07-21","current":-3.290541,"twenty":-30.572144,"median":-3.095464,"eighty":-1.551022,"marketCap":362101030},{"date":"2023-07-28","current":-3.088103,"twenty":-30.516979,"median":-3.150675,"eighty":-1.556458,"marketCap":339824121},{"date":"2023-08-04","current":-3.408323,"twenty":-30.494914,"median":-3.183801,"eighty":-1.556458,"marketCap":375062141},{"date":"2023-08-11","current":-4.28135,"twenty":-30.483881,"median":-3.202219,"eighty":-1.558388,"marketCap":416489682},{"date":"2023-08-18","current":-3.714451,"twenty":-30.461815,"median":-3.220608,"eighty":-1.559159,"marketCap":361341839},{"date":"2023-08-25","current":-3.955595,"twenty":-29.976368,"median":-3.226129,"eighty":-1.563362,"marketCap":384800250},{"date":"2023-09-01","current":-4.294041,"twenty":-29.799841,"median":-3.23165,"eighty":-1.566533,"marketCap":417724336},{"date":"2023-09-08","current":-4.848248,"twenty":-29.499747,"median":-3.272138,"eighty":-1.567359,"marketCap":471637526},{"date":"2023-09-15","current":-5.140158,"twenty":-29.398244,"median":-3.290541,"eighty":-1.568282,"marketCap":500034550},{"date":"2023-09-22","current":-6.723158,"twenty":-29.365146,"median":-3.323668,"eighty":-1.574468,"marketCap":654028850},{"date":"2023-09-29","current":-7.254081,"twenty":-29.093736,"median":-3.329649,"eighty":-1.579332,"marketCap":705677014},{"date":"2023-10-06","current":-7.108776,"twenty":-29.0143,"median":-3.33655,"eighty":-1.580231,"marketCap":691541727},{"date":"2023-10-13","current":-6.561087,"twenty":-28.93707,"median":-3.364155,"eighty":-1.580781,"marketCap":638262569},{"date":"2023-10-20","current":-5.884859,"twenty":-28.83998,"median":-3.393601,"eighty":-1.582043,"marketCap":572479118},{"date":"2023-10-27","current":-7.181429,"twenty":-28.83998,"median":-3.404643,"eighty":-1.582976,"marketCap":698609370},{"date":"2023-11-03","current":-8.796551,"twenty":-28.778196,"median":-3.414978,"eighty":-1.585216,"marketCap":855728521},{"date":"2023-11-10","current":-9.183057,"twenty":-28.531059,"median":-3.488347,"eighty":-1.588578,"marketCap":882142780},{"date":"2023-11-17","current":-9.541281,"twenty":-28.522233,"median":-3.577635,"eighty":-1.590373,"marketCap":916554542},{"date":"2023-11-24","current":-7.960544,"twenty":-28.486927,"median":-3.714451,"eighty":-1.597553,"marketCap":764705816},{"date":"2023-12-01","current":-7.932114,"twenty":-28.3435,"median":-3.818505,"eighty":-1.597628,"marketCap":761974723},{"date":"2023-12-08","current":-6.629996,"twenty":-28.288335,"median":-3.921888,"eighty":-1.604472,"marketCap":636890701},{"date":"2023-12-15","current":-7.005279,"twenty":-28.166973,"median":-3.930325,"eighty":-1.604472,"marketCap":672941118},{"date":"2023-12-22","current":-7.625064,"twenty":-28.155941,"median":-3.948568,"eighty":-1.609186,"marketCap":732478928},{"date":"2023-12-29","current":-8.239163,"twenty":-28.109602,"median":-3.95348,"eighty":-1.614472,"marketCap":791470519},{"date":"2024-01-05","current":-7.096257,"twenty":-28.065471,"median":-3.968578,"eighty":-1.622093,"marketCap":681680613},{"date":"2024-01-12","current":-6.527646,"twenty":-27.977208,"median":-4.0254,"eighty":-1.638882,"marketCap":627058769},{"date":"2024-01-19","current":-6.374122,"twenty":-27.835987,"median":-4.111281,"eighty":-1.640482,"marketCap":612310871},{"date":"2024-01-26","current":-6.533333,"twenty":-27.703592,"median":-4.171354,"eighty":-1.640482,"marketCap":627604987},{"date":"2024-02-02","current":-8.72327,"twenty":-27.637395,"median":-4.255382,"eighty":-1.640482,"marketCap":837974720},{"date":"2024-02-09","current":-8.72327,"twenty":-27.482934,"median":-4.288732,"eighty":-1.642473,"marketCap":837974720},{"date":"2024-02-16","current":-8.471582,"twenty":-27.471901,"median":-4.372816,"eighty":-1.643211,"marketCap":813797089},{"date":"2024-02-23","current":-7.710798,"twenty":-27.471901,"median":-4.404546,"eighty":-1.649935,"marketCap":740714703},{"date":"2024-03-01","current":-7.093019,"twenty":-27.26007,"median":-4.484417,"eighty":-1.657755,"marketCap":681369608},{"date":"2024-03-08","current":-8.048289,"twenty":-27.074717,"median":-4.574398,"eighty":-1.659876,"marketCap":773134709},{"date":"2024-03-15","current":-6.693224,"twenty":-27.023966,"median":-4.775633,"eighty":-1.660395,"marketCap":646933553},{"date":"2024-03-22","current":-6.681654,"twenty":-27.010727,"median":-4.879016,"eighty":-1.66369,"marketCap":645815258},{"date":"2024-03-28","current":-6.47918,"twenty":-26.99528,"median":-4.962473,"eighty":-1.675511,"marketCap":626245099},{"date":"2024-04-05","current":-6.080016,"twenty":-26.887158,"median":-5.075777,"eighty":-1.686808,"marketCap":587663927},{"date":"2024-04-12","current":-6.681654,"twenty":-26.814341,"median":-5.188809,"eighty":-1.696965,"marketCap":645815258},{"date":"2024-04-19","current":-5.727132,"twenty":-26.723871,"median":-5.409271,"eighty":-1.704543,"marketCap":553555935},{"date":"2024-04-26","current":-5.686637,"twenty":-26.620162,"median":-5.718454,"eighty":-1.706728,"marketCap":549641904},{"date":"2024-05-03","current":-5.827465,"twenty":-26.569411,"median":-5.758022,"eighty":-1.70792,"marketCap":563253637},{"date":"2024-05-10","current":-5.536514,"twenty":-26.542931,"median":-5.806223,"eighty":-1.712194,"marketCap":549991794},{"date":"2024-05-17","current":-5.435237,"twenty":-26.474527,"median":-5.744487,"eighty":-1.717177,"marketCap":539930968},{"date":"2024-05-24","current":-4.911968,"twenty":-26.41495,"median":-5.715984,"eighty":-1.721379,"marketCap":487950036},{"date":"2024-05-31","current":-5.41273,"twenty":-26.397298,"median":-5.614389,"eighty":-1.72446,"marketCap":537695229},{"date":"2024-06-07","current":-7.47767,"twenty":-26.214152,"median":-5.709777,"eighty":-1.726559,"marketCap":742824282},{"date":"2024-06-14","current":-7.010667,"twenty":-25.940536,"median":-5.727132,"eighty":-1.7267,"marketCap":696432698},{"date":"2024-06-21","current":-6.425507,"twenty":-25.905231,"median":-5.758022,"eighty":-1.727263,"marketCap":638303484},{"date":"2024-06-28","current":-6.30735,"twenty":-25.883165,"median":-5.784982,"eighty":-1.729362,"marketCap":626565854},{"date":"2024-07-05","current":-6.003517,"twenty":-25.746357,"median":-5.836143,"eighty":-1.733496,"marketCap":596383378},{"date":"2024-07-12","current":-7.033174,"twenty":-25.078757,"median":-5.882203,"eighty":-1.738766,"marketCap":698668437},{"date":"2024-07-15","current":-6.920643,"twenty":-24.825995,"median":-5.884859,"eighty":-1.740093,"marketCap":687489742},{"date":"2024-08-02","current":-9.261283,"twenty":-24.573232,"median":-5.885097,"eighty":-1.741419,"marketCap":920006598},{"date":"2024-08-09","current":-6.650423,"twenty":-23.992471,"median":-5.922852,"eighty":-1.75225,"marketCap":729059316},{"date":"2024-08-16","current":-6.467719,"twenty":-23.921891,"median":-6.003517,"eighty":-1.759611,"marketCap":709030214},{"date":"2024-08-23","current":-6.01879,"twenty":-23.731204,"median":-6.018435,"eighty":-1.763065,"marketCap":659815849},{"date":"2024-08-30","current":-6.02923,"twenty":-23.589644,"median":-6.02401,"eighty":-1.764859,"marketCap":660960369},{"date":"2024-09-06","current":-6.175393,"twenty":-23.5677,"median":-6.02401,"eighty":-1.767614,"marketCap":676983650},{"date":"2024-09-13","current":-6.185833,"twenty":-23.539487,"median":-6.080016,"eighty":-1.772239,"marketCap":678128171},{"date":"2024-09-20","current":-7.099353,"twenty":-23.498734,"median":-6.09668,"eighty":-1.775172,"marketCap":778273681},{"date":"2024-09-27","current":-6.378978,"twenty":-23.467386,"median":-6.129618,"eighty":-1.784148,"marketCap":699301793},{"date":"2024-10-04","current":-6.03445,"twenty":-23.432903,"median":-6.146644,"eighty":-1.794098,"marketCap":661532629},{"date":"2024-10-11","current":-5.825646,"twenty":-23.406256,"median":-6.109202,"eighty":-1.794504,"marketCap":638642226},{"date":"2024-10-18","current":-6.425959,"twenty":-23.401554,"median":-6.125802,"eighty":-1.794826,"marketCap":704452133},{"date":"2024-10-25","current":-6.117972,"twenty":-23.360801,"median":-6.129618,"eighty":-1.795797,"marketCap":670688790},{"date":"2024-10-31","current":-6.070991,"twenty":-23.276161,"median":-6.129618,"eighty":-1.799329,"marketCap":665538449},{"date":"2024-11-08","current":-6.47294,"twenty":-23.171143,"median":-6.146644,"eighty":-1.810933,"marketCap":709602474},{"date":"2024-11-15","current":-4.713934,"twenty":-23.124121,"median":-6.133555,"eighty":-1.813276,"marketCap":578300679},{"date":"2024-11-22","current":-3.673135,"twenty":-23.111582,"median":-6.125802,"eighty":-1.816307,"marketCap":450616469},{"date":"2024-11-29","current":-4.723268,"twenty":-23.111582,"median":-6.113587,"eighty":-1.816534,"marketCap":579445829},{"date":"2024-12-06","current":-4.797944,"twenty":-23.056722,"median":-6.096269,"eighty":-1.81972,"marketCap":588607028},{"date":"2024-12-13","current":-3.136399,"twenty":-23.025374,"median":-6.080723,"eighty":-1.81972,"marketCap":384770352},{"date":"2024-12-20","current":-2.702344,"twenty":-22.970514,"median":-6.065771,"eighty":-1.820535,"marketCap":331520884},{"date":"2024-12-27","current":-2.949709,"twenty":-22.964244,"median":-6.03624,"eighty":-1.820535,"marketCap":361867355},{"date":"2025-01-03","current":-2.599664,"twenty":-22.939165,"median":-6.02923,"eighty":-1.820535,"marketCap":318924236},{"date":"2025-01-10","current":-3.477925,"twenty":-22.876469,"median":-6.01879,"eighty":-1.822136,"marketCap":426668331},{"date":"2025-01-17","current":-3.193642,"twenty":-22.774587,"median":-6.003517,"eighty":-1.825707,"marketCap":391792832},{"date":"2025-01-24","current":-3.53841,"twenty":-22.704053,"median":-5.990273,"eighty":-1.827693,"marketCap":434088649},{"date":"2025-01-31","current":-3.828742,"twenty":-22.594334,"median":-5.957512,"eighty":-1.834402,"marketCap":469706180},{"date":"2025-02-07","current":-3.780353,"twenty":-22.53007,"median":-5.92384,"eighty":-1.857836,"marketCap":463769925},{"date":"2025-02-14","current":-2.921457,"twenty":-22.501856,"median":-5.914388,"eighty":-1.859317,"marketCap":358401398},{"date":"2025-02-21","current":-3.072671,"twenty":-22.414081,"median":-5.884859,"eighty":-1.860547,"marketCap":376952195},{"date":"2025-02-28","current":-2.667417,"twenty":-22.390569,"median":-5.874802,"eighty":-1.860547,"marketCap":327236059},{"date":"2025-03-07","current":-2.715806,"twenty":-22.33571,"median":-5.827465,"eighty":-1.86056,"marketCap":333172314},{"date":"2025-03-14","current":-2.643223,"twenty":-22.33571,"median":-5.771502,"eighty":-1.864548,"marketCap":324267931},{"date":"2025-03-21","current":-2.174431,"twenty":-22.312198,"median":-5.727132,"eighty":-1.866702,"marketCap":281532227},{"date":"2025-03-28","current":-2.216653,"twenty":-21.990878,"median":-5.698207,"eighty":-1.879271,"marketCap":286998873},{"date":"2025-04-04","current":-1.768044,"twenty":-21.943855,"median":-5.536514,"eighty":-1.864548,"marketCap":228915767},{"date":"2025-04-11","current":-1.799711,"twenty":-21.943855,"median":-5.440863,"eighty":-1.85901,"marketCap":233015751},{"date":"2025-04-17","current":-2.248319,"twenty":-21.881158,"median":-5.42117,"eighty":-1.86024,"marketCap":291098856},{"date":"2025-04-25","current":-2.69165,"twenty":-21.859214,"median":-5.383057,"eighty":-1.860547,"marketCap":348498631},{"date":"2025-05-02","current":-2.791927,"twenty":-21.838838,"median":-5.35724,"eighty":-1.860557,"marketCap":361481913},{"date":"2025-05-09","current":-2.465705,"twenty":-21.783978,"median":-5.243934,"eighty":-1.86375,"marketCap":319244711},{"date":"2025-05-16","current":-2.489629,"twenty":-21.7589,"median":-5.196108,"eighty":-1.866271,"marketCap":320895789},{"date":"2025-05-23","current":-2.739123,"twenty":-21.699338,"median":-5.140158,"eighty":-1.876757,"marketCap":353053789},{"date":"2025-05-30","current":-2.81344,"twenty":-21.633506,"median":-5.097644,"eighty":-1.882441,"marketCap":362632768},{"date":"2025-06-06","current":-2.234827,"twenty":-21.589619,"median":-5.025932,"eighty":-1.884554,"marketCap":288053576},{"date":"2025-06-13","current":-2.155201,"twenty":-21.536326,"median":-4.911968,"eighty":-1.891756,"marketCap":277790384},{"date":"2025-06-20","current":-2.176435,"twenty":-21.489304,"median":-4.877288,"eighty":-1.897748,"marketCap":280527235},{"date":"2025-06-27","current":-2.42062,"twenty":-21.462658,"median":-4.823096,"eighty":-1.899533,"marketCap":312001023},{"date":"2025-07-03","current":-2.425929,"twenty":-21.453253,"median":-4.770454,"eighty":-1.90021,"marketCap":312685235},{"date":"2025-07-11","current":-2.574563,"twenty":-21.429742,"median":-4.723268,"eighty":-1.905648,"marketCap":331843193},{"date":"2025-07-18","current":-2.394078,"twenty":-21.403096,"median":-4.69576,"eighty":-1.916564,"marketCap":308579959},{"date":"2025-07-25","current":-2.425929,"twenty":-21.371747,"median":-4.575536,"eighty":-1.919724,"marketCap":312685235},{"date":"2025-08-01","current":-2.728506,"twenty":-21.362343,"median":-4.517909,"eighty":-1.932406,"marketCap":351685363},{"date":"2025-08-08","current":-2.505554,"twenty":-21.305916,"median":-4.484417,"eighty":-1.934169,"marketCap":322948427},{"date":"2025-08-15","current":-2.529224,"twenty":-21.216573,"median":-4.419773,"eighty":-1.942171,"marketCap":359895917},{"date":"2025-08-22","current":-2.672154,"twenty":-21.160146,"median":-4.37544,"eighty":-1.948573,"marketCap":380234182},{"date":"2025-08-29","current":-2.662507,"twenty":-21.160146,"median":-4.291386,"eighty":-1.954165,"marketCap":378861496},{"date":"2025-09-05","current":-3.062848,"twenty":-21.160146,"median":-4.280614,"eighty":-1.976533,"marketCap":435827989},{"date":"2025-09-12","current":-3.858706,"twenty":-21.105286,"median":-4.235373,"eighty":-1.983895,"marketCap":549074632},{"date":"2025-09-19","current":-4.104699,"twenty":-21.026915,"median":-4.164942,"eighty":-1.984432,"marketCap":584078139},{"date":"2025-09-26","current":-3.950351,"twenty":-21.019078,"median":-4.135324,"eighty":-1.984584,"marketCap":562115154},{"date":"2025-10-03","current":-5.373249,"twenty":-21.003404,"median":-4.190024,"eighty":-1.988585,"marketCap":764586425},{"date":"2025-10-10","current":-5.151373,"twenty":-21.003404,"median":-4.239754,"eighty":-1.988585,"marketCap":733014633},{"date":"2025-10-17","current":-4.630448,"twenty":-21.003404,"median":-4.280614,"eighty":-1.98971,"marketCap":658889558},{"date":"2025-10-24","current":-3.902117,"twenty":-20.815314,"median":-4.275392,"eighty":-1.995776,"marketCap":555251721},{"date":"2025-10-31","current":-4.23493,"twenty":-20.50183,"median":-4.237564,"eighty":-2.018056,"marketCap":602609408},{"date":"2025-11-07","current":-3.950351,"twenty":-20.431297,"median":-4.23493,"eighty":-2.026168,"marketCap":562115154},{"date":"2025-11-14","current":-3.635441,"twenty":-20.337251,"median":-4.188672,"eighty":-2.042786,"marketCap":545159788}],"updateTime":1763392978641},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OLMA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582855313","title":"Oppenheimer Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582855313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582855313?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:55","pubTimestamp":1762811712,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Olema Pharmaceuticals, with a price target of $22.00. Biegl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-olema-pharmaceuticals-olma-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-olema-pharmaceuticals-olma-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OLMA","OPY"],"gpt_icon":0},{"id":"2582804702","title":"Promising Developments and Strategic Collaborations Boost Olema Pharmaceuticals’ Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2582804702","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582804702?lang=en_us&edition=fundamental","pubTime":"2025-11-11 03:25","pubTimestamp":1762802717,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Olema Pharmaceuticals, with a price target of $27.00. Sam S...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-developments-and-strategic-collaborations-boost-olema-pharmaceuticals-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-developments-and-strategic-collaborations-boost-olema-pharmaceuticals-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OLMA"],"gpt_icon":0},{"id":"2582809872","title":"Optimistic Buy Rating for Olema Pharmaceuticals Driven by Unique Phase III Trials and Promising Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2582809872","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582809872?lang=en_us&edition=fundamental","pubTime":"2025-11-11 01:35","pubTimestamp":1762796124,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren has maintained their bullish stance on OLMA stock, giving a Buy rating on October 27. Tyler Van Buren’s rating is ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-olema-pharmaceuticals-driven-by-unique-phase-iii-trials-and-promising-market-potential-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-buy-rating-for-olema-pharmaceuticals-driven-by-unique-phase-iii-trials-and-promising-market-potential-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["III","OLMA"],"gpt_icon":0},{"id":"2582875341","title":"Olema Pharmaceuticals Q3 EPS $(0.49) Misses $(0.45) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582875341","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582875341?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:17","pubTimestamp":1762777055,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.45) by 8.89 percent. This is a 18.33 percent increase over losses of $(0.60) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48748432/olema-pharmaceuticals-q3-eps-0-49-misses-0-45-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA"],"gpt_icon":0},{"id":"2582574873","title":"Olema Pharmaceuticals posts Q3 net loss of $42.2 million on higher R&D spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2582574873","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582574873?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:01","pubTimestamp":1762776092,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals Inc. reported a net loss of $42.2 million for the third quarter ended September 30, 2025, compared to a net loss of $34.6 million in the same period in 2024. GAAP research and development expenses increased to $40.0 million from $33.2 million in the prior year quarter, mainly due to higher clinical development-related activities. Non-GAAP research and development expenses were $37.4 million, up from $28.9 million. The company ended the quarter with $329.0 million in cash, cash equivalents, and marketable securities. Key business developments included a new clinical trial agreement with Pfizer to evaluate palazestrant in combination with atirmociclib in ER+/HER2- metastatic breast cancer, initiation of the OPERA-02 Phase 3 trial of palazestrant with ribociclib, and presentation of new data from a Phase 1b/2 study at ESMO 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accur","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL6k6rN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","BK4505","IE00BBT3K403.USD","LU0225284248.USD","LU2095319765.USD","LU1894683264.USD","SG9999003800.SGD","LU0321505868.SGD","OLMA","SG9999013999.USD","IE00B3QW5Z07.USD","IE000M9KFDE8.USD","LU0456855351.SGD","LU0122379950.USD","IE00BKPKM429.USD","BK4534","BK4588","IE00BGHQF748.EUR","SG9999002232.USD","LU0868494617.USD","LU0058720904.USD","LU0321505439.SGD","SG9999001176.SGD","IE00B64PRP62.GBP","LU0289739699.SGD","LU0234572021.USD","LU1894683348.USD","LU2210149790.SGD","NDAQ","LU2210150020.SGD","BK4585","BK4592","LU0985481810.HKD","SGXZ57979304.SGD","LU1066051498.USD","BK4550","LU1066053197.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","BK4112","IE00BLSP4452.SGD","LU0306807586.USD","BK4533","SG9999001176.USD","BK4007","BK4568","BK4139","LU1057294990.SGD","IE0002270589.USD"],"gpt_icon":1},{"id":"2582873662","title":"BRIEF-Olema Pharmaceuticals Q3 Net Income USD -42.217 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873662","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873662?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776046,"startTime":"0","endTime":"0","summary":"BRIEF-Olema Pharmaceuticals Q3 Net Income USD -42.217 Million\n\n\nNov 10 (Reuters) - Olema Pharmaceuticals Q3 operating expenses USD 45.877 million.\n\nQ3 income from operations USD -45.877 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLX94BB10:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","OLMA"],"gpt_icon":0},{"id":"2582898873","title":"Olema Pharmaceuticals Q3 Income From Operations USD -45.877 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582898873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582898873?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLX94BB10:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","OLMA"],"gpt_icon":0},{"id":"2582187321","title":"Press Release: Olema Oncology Reports Third Quarter 2025 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582187321","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582187321?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776000,"startTime":"0","endTime":"0","summary":"-- Announced new clinical trial agreement with Pfizer to evaluate. palazestrant in combination with atirmociclib in ER+/HER2- metastatic. -- Initiated OPERA-02 Phase 3 trial of palazestrant in combination with. -- Presented compelling new data from Phase 1b/2 study of palazestrant plus. -- Ended the quarter with $329.0 million in cash, cash equivalents, and. Bohen continued, \"Enrollment in the OPERA-01 trial evaluating palazestrant as a monotherapy in second- and third-line ER+/HER2- metastatic breast cancer continues to progress well and we remain on track for top-line data in the second half of next year. The Phase 1/2 study of our KAT6 inhibitor, OP-3136, recently expanded into combinations with fulvestrant and palazestrant and continues to benefit from strong investigator interest. As we look ahead to 2026, we remain focused on sustaining positive momentum across the business, transforming the breast cancer treatment paradigm, and bringing palazestrant to market.\". ribociclib at th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","BK4550","LU0456855351.SGD","LU0122379950.USD","LU1883839398.USD","LU0321505868.SGD","LU0985481810.HKD","IE0002270589.USD","SG9999011175.SGD","SG9999002232.USD","LU0306807586.USD","LU0225771236.USD","BK4139","LU1066051498.USD","LU1894683348.USD","LU0170899867.USD","BK4023","IE00BLSP4452.SGD","SG9999002224.SGD","LU0306806265.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU0225284248.USD","LU0321505439.SGD","IE00BBT3K403.USD","OP.USD.HKCC","LU0868494617.USD","SG9999003800.SGD","LU0289739699.SGD","BK4533","OLMA","BK4534","LU0058720904.USD","BK4599","LU1057294990.SGD","BK4585","SG9999013999.USD","SG9999001176.SGD","IE00BLSP4239.USD","LU0234572021.USD","BK4007","BK4588","SGXZ57979304.SGD","BK4581","OPRA","BK4568","IE000M9KFDE8.USD","LU1023059063.AUD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2581831747","title":"Olema Pharmaceuticals Inc  expected to post a loss of 48 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831747","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581831747?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:36","pubTimestamp":1762551366,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals Inc  expected to post a loss of48cents a share - Earnings Preview Olema Pharmaceuticals Inc OLMA.OQ OLMA.O is expected to  show no change in quarterly revenue when it reports  re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL8N3WJ2X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OLMA","BK4505"],"gpt_icon":0},{"id":"2581625917","title":"Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581625917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581625917?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:30","pubTimestamp":1762291800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nTUA4ZBZYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","OLMA"],"gpt_icon":0},{"id":"2580255672","title":"Olema Pharmaceuticals Inc. to Participate in Jefferies London Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2580255672","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580255672?lang=en_us&edition=fundamental","pubTime":"2025-11-04 05:30","pubTimestamp":1762205436,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on targeted therapies for breast cancer, will participate in several upcoming investor conferences, including a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on November 10, 2025, a presentation at the UBS Global Healthcare Conference on November 12, 2025, and a fireside chat at the Jefferies London Healthcare Conference on November 19, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL2SfTD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU2095319765.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210150020.SGD","OLMA","BK4139","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","LU2210149790.SGD","BK4112","BK4588","BK4585","LU0314104364.USD"],"gpt_icon":0},{"id":"2579177250","title":"Olema Pharmaceuticals Announces Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib for Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2579177250","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579177250?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:30","pubTimestamp":1761856213,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals Inc. has announced that it will present a trial-in-progress poster for the Phase 3 OPERA-02 study at the 2025 San Antonio Breast Cancer Symposium , scheduled for December 9-12, 2025. The OPERA-02 trial is evaluating palazestrant in combination with ribociclib as a first-line treatment for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative  advanced or metastatic breast cancer. The poster presentation will provide details on the study design and will be made available on Olema's website in accordance with SABCS embargo policies. Results from the trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL4K3pDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4505","LU2095319765.USD","LU2210150020.SGD","BK4585","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","OLMA","BK4588","NDAQ","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139"],"gpt_icon":0},{"id":"2578649012","title":"Promising Outlook for Olema Pharmaceuticals: Buy Rating Driven by Palazestrant’s Potential in Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578649012","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578649012?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:55","pubTimestamp":1761569742,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Anupam Rama has maintained their bullish stance on OLMA stock, giving a Buy rating on October 20. Anupam Rama has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-outlook-for-olema-pharmaceuticals-buy-rating-driven-by-palazestrants-potential-in-breast-cancer-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-outlook-for-olema-pharmaceuticals-buy-rating-driven-by-palazestrants-potential-in-breast-cancer-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OLMA"],"gpt_icon":0},{"id":"2577836925","title":"JPMorgan healthcare analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2577836925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577836925?lang=en_us&edition=fundamental","pubTime":"2025-10-23 22:15","pubTimestamp":1761228909,"startTime":"0","endTime":"0","summary":"Healthcare Analysts discuss the recently held ESMO 2025 (European Society for Medical Oncology) with Olema (OLMA) on an Analyst/Industry conference...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jpmorgan-healthcare-analysts-hold-an-analyst-industry-conference-call-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jpmorgan-healthcare-analysts-hold-an-analyst-industry-conference-call-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2054465674.USD","LU0203347892.USD","LU1988902786.USD","XLV","LU1496350502.SGD","LU0942090050.USD","LU1162221912.USD","LU2505996681.GBP","LU2237443465.HKD","LU0820561818.USD","LU1116320901.HKD","LU0211331839.USD","LU2505996509.AUD","JPM","LU1366192091.USD","OLMA","LABU","LU0640476718.USD","IE0034235303.USD","IE00B3S45H60.SGD","LU1032466523.USD","LU0215105999.USD","IE00BJLML261.HKD","IE00BDCRKT87.USD","LU0689472784.USD","LU1280957306.USD","LU1261432733.SGD","XBI","IE00B1XK9C88.USD","IE00BJTD4V19.USD","LU0203345920.USD","LU1064131342.USD","LU0256863811.USD","LU1145028129.USD","LU2023250843.SGD","IE0034235188.USD","IE0034235295.USD","LU0267386448.USD","LU0048584097.USD","LU0320765646.SGD","LU0868494708.USD","LU1894683264.USD","IE00BKDWB100.SGD","LU2592432038.USD","IE00B1BXHZ80.USD","LU2236285917.USD","LU1914381329.SGD","LU2552382215.SGD","BK4585","LU1496350171.SGD"],"gpt_icon":0},{"id":"2577899224","title":"Olema Pharmaceuticals Reports Positive Phase 1b/2 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2577899224","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577899224?lang=en_us&edition=fundamental","pubTime":"2025-10-21 06:04","pubTimestamp":1760997847,"startTime":"0","endTime":"0","summary":"An update from Olema Pharmaceuticals ( ($OLMA) ) is now available. On October 18, 2025, Olema Pharmaceuticals announced new data from its Phase 1b/...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/olema-pharmaceuticals-reports-positive-phase-1b-2-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/olema-pharmaceuticals-reports-positive-phase-1b-2-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OLMA","BK4505","BK4139"],"gpt_icon":0},{"id":"2576865773","title":"Olema Pharmaceuticals Shares Fall After Roche's Breast Cancer Data Weighs on Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2576865773","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576865773?lang=en_us&edition=fundamental","pubTime":"2025-10-20 23:25","pubTimestamp":1760973957,"startTime":"0","endTime":"0","summary":"Olema Pharmaceuticals (OLMA) shares fell 14% in Monday trading even after encouraging results for its breast cancer drug, a decline attributed to investor reaction to Roche Holding's Phase 3 evERA tri","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4505","OLMA"],"gpt_icon":0},{"id":"2576085162","title":"Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2576085162","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576085162?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:10","pubTimestamp":1760962200,"startTime":"0","endTime":"0","summary":"U.S. stock futures were higher this morning, with the Dow futures gaining around 0.2% on Monday.Shares of Olema Pharmaceuticals Inc  fell 18.3% to $7.64 in pre-market trading after the company announced new data from the Phase 1b/2 trial of palazestrant plus ribociclib in ER+/HER2- metastatic breast cancer at ESMO 2025.Olema Pharmaceuticals shares dipped 18.3% to $7.64 in pre-market trading.Here are some other stocks moving lower in pre-market trading.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/20/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/20/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/25/10/48299789/olema-pharmaceuticals-exelixis-genmab-and-other-big-stocks-moving-lower-in-mondays-pre-market-session","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/10/48299789/olema-pharmaceuticals-exelixis-genmab-and-other-big-stocks-moving-lower-in-mondays-pre-market-session","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["OLMA","BK4139","BK4532","BK4505","EXEL"],"gpt_icon":0},{"id":"2576859477","title":"Olema Pharmaceuticals Price Target Maintained With a $28.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859477","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859477?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:07","pubTimestamp":1760962020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OLMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 20, 2025 08:07 ET (12:07 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OLMA"],"gpt_icon":0},{"id":"2576856145","title":"Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’","url":"https://stock-news.laohu8.com/highlight/detail?id=2576856145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576856145?lang=en_us&edition=fundamental","pubTime":"2025-10-20 19:36","pubTimestamp":1760960166,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Matthew Biegler notes Olema Pharmaceuticals (OLMA) delivered stellar second-line data in combination with ribociclib at ESMO, t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oppenheimer-remains-bullish-on-olema-despite-jekyll-and-hyde-kinda-esmo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oppenheimer-remains-bullish-on-olema-despite-jekyll-and-hyde-kinda-esmo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OLMA","BK4139","BK4127","BK4505","OPY"],"gpt_icon":0},{"id":"2576001038","title":"Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2576001038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576001038?lang=en_us&edition=fundamental","pubTime":"2025-10-20 06:55","pubTimestamp":1760914506,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Olema Pharmaceuticals today and set a price target of $22.00. The company’s shares c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-olema-pharmaceuticals-olma-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-remains-a-buy-on-olema-pharmaceuticals-olma-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","OLMA","BK4505","BK4127","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}